Mission
BIOPHYTIS is a biotechnology company created in 2006, specialising in diseases associated with aging, particularly those affecting muscular and visual functions.
Aging science
By understanding the relationship between natural active substances and degeneration processes BIOPHYTIS is able to identify families of substances capable of acting directly on the mechanism of the disease.
Pipeline
BIOPHYTIS has a portfolio of first-in-class drug candidates, at various stages of development, for treating certain indications of sarcopenia and ARMD, for which there is currently no treatment.
News
27 June 2017

Participation of Biophytis to the European MIDCAP event in Hotel Pullman Paris Eiffel Tour – June 28 & 29, 2017

16 June 2017

Results of the General Shareholders’ Meeting  held on June 16, 2017. Read the Press release